Pharmaceuticals Wholesale & Distribution Market to grow by USD 896.5 Billion from 2024-2028, Driven by Growing Global Pharmaceutical Sales, Report on How AI is Driving Market Transformation – Technavio

NEW YORK, Feb. 6, 2025 /PRNewswire/ — Report with the AI impact on market trends – The global pharmaceuticals wholesale and distribution market size is estimated to grow by USD 896.5 billion from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of  9.45%  during the forecast period. Growing global pharmaceutical sales is driving market growth, with a trend towards emergence of drones in pharmaceuticals wholesale and distribution. However, increased complexities due to time-bound deliveries and customization of supply chain  poses a challenge. Key market players include A.F. Hauser Pharmaceutical Inc., Alfresa Holdings Corp., AmerisourceBergen Corp., Attain Med Inc., Cardinal Health Inc., China Resources Pharmaceutical Group Ltd., Dakota Drug Inc., FFF Enterprises Inc., J M Smith Corp., McKesson Corp., MEDIPAL HOLDINGS CORP., Medline Industries LP, Morris and Dickson Co. LLC, Mutual Drug, Owens and Minor Inc., PHOENIX Pharmahandel GmbH and Co KG, Shanghai Fosun Pharmaceutical Group Co. Ltd., Sinopharm Group Co. Ltd., SUZUKEN CO. LTD., and The Cigna Group.

Key insights into market evolution with AI-powered analysis. Explore trends, segmentation, and growth drivers- View Free Sample PDF

Market Driver

The Pharmaceutical Wholesale Distribution market is a significant segment of the pharmaceutical landscape. Wholesalers play a crucial role in this industry, acting as intermediaries between producers and retailers. Two types of wholesalers exist: Producer Wholesalers, who buy directly from manufacturers, and Merchant Wholesalers, who purchase from various sources. Branded Drugs and Generic Drugs are the two primary product categories. Ethical Pharma Products and Over-the-counter (OTC) Supply are essential sub-segments. The pharmaceutical landscape continues to evolve, with drug evaluation processes streamlining the introduction of Vaccines, Medical devices, and other innovations. Unmet medical needs drive the demand for new products. Generic Drug Promotion and Health Insurance schemes influence market dynamics. Track-and-trace systems ensure product authenticity and safety. The market includes Branded Pharmaceuticals, Generic Pharmaceuticals, and Over-the-counter (OTC) Pharmaceuticals. The Global Glycidol Market, a specialty chemical, is a significant component of this industry. Its applications include the production of polymers, resins, and surface active compounds used in Cosmetic Preparations, Laundry Detergents, Additives in plastics, Paints, Photographic Chemicals, Biocides, and Online/Offline sales channels. Valuation of Pharmaceutical Wholesale Distribution is influenced by market trends, production costs, and regulatory frameworks. 

Drones, unmanned aerial vehicles, are revolutionizing the logistics sector, particularly in the delivery of essential pharmaceutical supplies. In areas with inadequate road or railway infrastructure, drones offer a viable solution. They can transport pharmaceutical drugs and medicines to hard-to-reach remote destinations, improving market prospects for global pharmaceutical wholesale and distribution companies. Real-time information obtained from drones enables logistics firms to optimize their supply chain models effectively. This innovation in delivery methods is expected to significantly impact the pharmaceutical industry. 

Request Sample of our comprehensive report now to stay ahead in the AI-driven market evolution!

 Market Challenges

• Pharmaceutical Wholesale Distribution faces unique challenges in supplying branded and generic drugs to various healthcare providers and retailers. Wholesalers, including Producer Wholesalers and Merchant Wholesalers, play a crucial role in this supply chain. Agents and Brokers help facilitate transactions between producers and buyers. The pharmaceutical landscape includes ethical pharma products, OTC/Institutional Supply, vaccines, and medical devices. Unmet medical needs continue to drive demand for new drugs and treatments. Generic drug promotion requires careful regulation to ensure quality and safety. Health insurance schemes impact the distribution of branded pharmaceuticals, while track-and-trace systems ensure product authenticity. Valuation of the Pharmaceutical landscape includes branded and generic drug markets, as well as markets for vaccines, medical devices, and other related products. The production of polymers, resins, specialty chemicals, and diversified materials like glycidol is essential for pharmaceutical manufacturing. Glycidol is used in Surface Active Compounds, Cosmetic Preparations, Laundry Detergents, Additives in plastics, Paints, Photographic Chemicals, and Biocides. Online and offline sales channels continue to evolve, offering new opportunities and challenges for pharmaceutical wholesale distribution. The Global Glycidol Market is expected to grow due to its diverse applications.
• In the pharmaceuticals wholesale and distribution market, selecting an appropriate supply chain model is essential. Customers demand shorter lead times, while logistics companies aim for low operational costs. Healthcare supplies necessitate special handling, specific packaging, and customized supply chains to preserve product integrity. Logistical complexities arise from topographical challenges, technological advancements, and region-specific regulations and policies. These factors complicate the formulation of an effective supply chain model. The high criticality of healthcare supplies necessitates an agile and responsive supply chain to minimize lead times.

Discover how AI is revolutionizing market trends- Get your access now!

Segment Overview 

This pharmaceuticals wholesale and distribution market report extensively covers market segmentation by  

• Type
• Branded Drugs
• Generic Drugs
• End-user
• Retail Pharmacies
• Hospital Pharmacies
• Others
• Geography
• North America
• Asia
• Europe
• Rest Of World (ROW)

1.1 Branded drugs-  Pharmaceutical companies invest significantly in research and development to create branded drugs, which are approved by the FDA based on their safety, efficacy, and manufacturing methods. The high costs associated with R&D result in premium prices for these drugs, despite the availability of generic alternatives. In 2020, the FDA approved 53 new drugs, including Novartis AG’s Kisqali, Roche’s Ocrevus, and Gilead Sciences’ Veklury. This approval of innovative treatments is expected to drive growth in the global pharmaceuticals wholesale and distribution market.

Download a Sample of our comprehensive report today to discover how AI-driven innovations are reshaping competitive dynamics

Research Analysis

Pharmaceutical Wholesale Distribution refers to the process of purchasing pharmaceutical products from manufacturers or importers and then distributing them to retailers, hospitals, and other healthcare providers. Wholesalers play a crucial role in this supply chain, acting as intermediaries between producers and end-users. There are two main types of wholesalers: Producer Wholesalers, who buy directly from manufacturers, and Merchant Wholesalers, who buy from various sources and sell to multiple customers. Agents and Brokers facilitate the sale of pharmaceutical products by acting as intermediaries between buyers and sellers. Branded Drugs and Generic Drugs are the two main categories of pharmaceutical products. Ethical Pharma Products are prescription drugs, while Over-the-Counter (OTC) and Institutional Supply drugs do not require a prescription. The pharmaceutical landscape is constantly evolving, with new drugs and treatments emerging to address Unmet Medical Needs. Drug evaluation and approval processes are rigorous to ensure safety and efficacy. Vaccines and Medical Devices are essential components of modern healthcare. Generic Drug Promotion and Health Insurance Schemes impact the pharmaceutical market significantly. Track-and-trace systems ensure the authenticity and safety of pharmaceutical products. The Global Glycidol Market is a subsegment of the specialty chemicals industry, with applications in various sectors, including Polymers, Resins, Surface Active Compounds, Cosmetic Preparations, Laundry Detergents, Additives in plastics, Paints, and Photographic Chemicals. The production of Glycidol and its derivatives involves complex chemical processes and requires a high level of expertise. Valuation of Pharmaceutical Companies depends on various factors, including their product portfolio, market share, and financial performance.

Market Research Overview

The Pharmaceutical Wholesale Distribution market refers to the process of procuring, storing, and distributing pharmaceutical products from manufacturers to retailers, hospitals, and other healthcare providers. Wholesalers play a crucial role in this supply chain, acting as intermediaries between producers and end-users. There are two main types of wholesalers: Producer Wholesalers, who buy directly from manufacturers, and Merchant Wholesalers, who purchase from various sources and sell to multiple customers. Agents and Brokers facilitate sales and marketing activities, while Branded Drugs, Generic Drugs, Ethical Pharma Products, OTC/Institutional Supply cater to diverse pharmaceutical landscape. Drug evaluation, vaccines, medical devices, and unmet medical needs are significant areas of focus. Generic drug promotion, health insurance schemes, and track-and-trace systems are key considerations. The pharmaceutical industry encompasses various sectors like Branded pharmaceuticals, Generic pharmaceuticals, Over-the-counter (OTC) pharmaceuticals, and others. The Global Glycidol Market, a specialty chemical used in the production of polymers, resins, and diversified materials, is a significant segment. Glycidol finds applications in cosmetic preparations, laundry detergents, additives in plastics, paints, photographic chemicals, biocides, and online/offline sales channels. Valuation of this market depends on various factors including production capacity, demand, and pricing trends.

Table of Contents:

1 Executive Summary

2 Market Landscape

3 Market Sizing

4 Historic Market Size

5 Five Forces Analysis

6 Market Segmentation

• Type
• Branded Drugs
• Generic Drugs
• End-user
• Retail Pharmacies
• Hospital Pharmacies
• Others
• Geography
• North America
• Asia
• Europe
• Rest Of World (ROW)

7 Customer Landscape

8 Geographic Landscape

9 Drivers, Challenges, and Trends

10 Company Landscape

11 Company Analysis

12 Appendix

About Technavio

Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions.

With over 500 specialized analysts, Technavio’s report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

Contacts

Technavio Research

Jesse Maida

Media & Marketing Executive

US: +1 844 364 1100

UK: +44 203 893 3200

Email: media@technavio.com

Website: www.technavio.com/

View original content to download multimedia:https://www.prnewswire.com/news-releases/pharmaceuticals-wholesale–distribution-market-to-grow-by-usd-896-5-billion-from-2024-2028–driven-by-growing-global-pharmaceutical-sales-report-on-how-ai-is-driving-market-transformation—technavio-302369842.html

SOURCE Technavio